Mind Medicine (MindMed)
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MNMD and buy or sell other stocks, ETFs, and their options commission-free!About MNMD
Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine.
CEORobert Barrow
CEORobert Barrow
Employees41
Employees41
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2019
Founded2019
Employees41
Employees41
MNMD Key Statistics
Market cap596.85M
Market cap596.85M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume6.34M
Average volume6.34M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.67
52 Week high$3.67
52 Week low$0.58
52 Week low$0.58
Stock Snapshot
The current Mind Medicine (MindMed)(MNMD) stock price is $15.38, with a market capitalization of 596.85M.
During the trading day, Mind Medicine (MindMed)(MNMD) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 6.34M.
The stock's 52-week range extends from a low of $0.58 to a high of $3.67.
The stock's 52-week range extends from a low of $0.58 to a high of $3.67.
People also own
Based on the portfolios of people who own MNMD. This list is generated using Robinhood data, and it’s not a recommendation.